“Strategies are based on an evidence-based approach, epidemiological stratification, equity of access to essential interventions and the strengthening of health system resilience.”
- Evidence-based approach
- Epidemiological stratification
- Equitable access to essential interventions
- Health system resilience
The six strategic axes
Select an axis to discover the actions it includes.
Improving and optimizing prevention
- Targeted ITN distribution
- IRS
- Larval source management
- Spatial emanators
- IPTp, MCP, SMC, PDMC
- Malaria vaccination (MV)
- MDA in hotspot areas
Strengthening case management
- Diagnosis (RDT, TS)
- Treatment (ACT, AP, ASAQ)
- CM in health facilities and CCS
- Therapeutic rotation based on resistance
Epidemiological surveillance and response
- DHIS2, NMDR, Dashboard Malaria
- Rapid response
- Vector and parasite surveillance
- Resistance monitoring
Monitoring, evaluation, research and innovation
- Performance framework
- Data quality
- Operational research
- Technological innovations
Social and behaviour change communication (SBCC)
- Community mobilization
- Targeted messages
- Engagement of local leaders
SBCC fundingThe communication budget (SBCC) consists of 0.5% taken from the mass campaign and 0.5% taken from public-sector case management (CM).
Governance, leadership and programme management
- Strengthening the NMCP
- Multisectoral coordination
- Resource mobilization
- Institutional accountability
Priority interventions
Five areas of action to achieve the greatest impact.
Prevention
- ITN, IRS, LSM
- MV, MCP, SMC, PDMC
- MDA
Case management
- Rapid diagnosis
- ACT treatment
- Community CM
Surveillance
- DHIS2
- NMDR
- Scorecard
Communication
- SBCC
- Social mobilization
Management
- Leadership
- Coordination
- Financing
Impact objectives 2026–2030
Ambitious targets: halve the malaria burden in five years.
Budget and funding
The cost of the 2026–2030 Strategic Plan, the donors funding it and what the data show.
2,413,012,468 USD over the five years of the Strategic Plan
−3.3% compared with the initial budget before reframing (−81,243,382 USD)
Identified funding 2026–2030
Breakdown of the total cost by donor as recorded in the source file
Amounts in millions of USD · percentages: share of identified funding
Table B – Identified funding of the NSP 2026–2030Breakdown of the total cost by donor as recorded in the source file
| Status | ||||
|---|---|---|---|---|
| Congolese Government | 106,207,777.80 | 4.40% | 7.8% | Funding allocated |
| Global Fund | 354,025,926.00 | 14.67% | 26.0% | Funding allocated |
| USG · U.S. Government | 238,008,000.00 | 9.86% | 17.5% | Funding allocated |
| Gavi, the Vaccine Alliance | 280,898,575.90 | 11.64% | 20.7% | Funding allocated |
| GiveWell | 276,000,000.00 | 11.44% | 20.3% | Funding allocated |
| AMF · Against Malaria Foundation | 104,642,713.52 | 4.34% | 7.7% | Funding allocated |
| Total identified funding | 1,359,782,993.22 | 56.35% | 100.0% | |
| Remaining to be funded | 1,053,229,474.78 | 43.65% | ||
| Total cost of the 2026–2030 Strategic Plan | 2,413,012,468.00 | 100.00% |
Click a column header to sort. “% of total cost”: share of the Plan’s total cost (2,413,012,468 USD); “% of identified funding”: share of the total allocated funding (1,359,782,993.22 USD). Percentages rounded.
Table C – Funding gap of the NSP 2026–2030Difference between the total cost and the explicitly allocated funding
| Item | Amount (USD) | % of total cost | Comment |
|---|---|---|---|
| Total cost of the NSP | 2,413,012,468.00 | 100.0% | Reference from Table A |
| Explicitly allocated funding | 1,359,782,993.22 | 56.4% | Global Fund + USG + AMF + GiveWell + Gavi + Government |
| GAP TO BE MOBILIZED | 1,053,229,474.78 | 43.6% | Additional resources to be mobilized |
Hover over the chart to see the details.
A nearly stable budget
The total of 2,413,012,468 USD represents the total budget for the five years covered by this 2026–2030 Strategic Plan. It is comparable to that of the initial Strategic Plan (2,494,255,850 USD): a decrease of 3.3% (81,243,382 USD) compared with the initial budget before reframing. This budget includes vaccine costs, which could also appear in the budget of the Expanded Programme on Immunization (EPI).
Advocacy and domestic resources
In its current configuration, this status quo in the evolution of the budget raises the question of strengthening advocacy for resource mobilization, with a view to diversifying the sources of funding for malaria control, in a context of declining international funding. An increase in domestic resource mobilization may prove a major indicator of the country’s capacity to cover, even partially, the budget gap in implementing this Strategic Plan.
Funding currently allocated
The total amount of funding currently allocated stands at 1,359,782,993.22 USD, with all the listed funds already having “Funding allocated” status. International donors provide almost all of this budget coverage, led by the Global Fund (26.0%, or 354.0 million USD), followed by Gavi (20.7%), GiveWell (20.3%), the U.S. government USG (17.5%) and AMF (7.7%).
↗Government7.8%106.2 million USD
↗Global Fund26.0%354.0 million USD
↗USG17.5%238.0 million USD
↗Gavi20.7%280.9 million USD
↗GiveWell20.3%276.0 million USD
↗AMF7.7%104.6 million USD
The Government’s direct contribution stands at 106.2 million USD, representing a 7.8% share of the plan’s total identified funding. Percentages are expressed as a share of total allocated funding (1,359,782,993.22 USD).
A significant funding base
The Malaria NSP 2026–2030 already has a significant base of funding of 1,359,782,993.22 USD, from the Global Fund, USG, Gavi, GiveWell, AMF and the Government of the DRC. However, given an overall need estimated at 2.413 billion USD, significant additional resources remain necessary to ensure full coverage of the planned interventions.
The residual gap represents a structured investment opportunity within a single, costed national framework aligned with malaria control priorities. Additional contributions can be directed to the interventions and periods with the largest funding shortfalls, while ensuring complementarity with funding already allocated.
Point of attention
Against an overall need of 2.413 billion USD for 2026–2030, 1,359,782,993.22 USD of funding is currently explicitly allocated, while 1,053,229,474.78 USD remains to be mobilized. The NSP thus provides a costed national framework enabling partners to contribute in a complementary and coordinated way to funding the priority malaria control interventions in the DRC.
The overall cost of the National Strategic Plan (NSP) for 2026–2030 stands at 2,413,012,468.00 USD. Against this budget need, the funding explicitly allocated by all partners (Global Fund, USG, AMF, GiveWell, Gavi and the Government) reaches 1,359,782,993.22 USD, covering 56.4% of the plan’s total cost. Consequently, a major funding gap remains to be mobilized, amounting to 1,053,229,474.78 USD, or 43.6% of the overall envelope required for full implementation of the activities.
Major challenges and key recommendations
Major challenges
- Governance and leadership
- Insufficient human resources
- Dependence on external funding
- Resistance to insecticides and antimalarials
- Low use of data
- Security constraints
Key recommendations
- Strengthen epidemiological stratification
- Prioritize high-impact interventions
- Improve data quality
- Accelerate malaria vaccination
- Strengthen community CM
- Step up domestic resource mobilization
Acronyms and abbreviations
- ACT
- Artemisinin-based combination therapies
- AMF
- Against Malaria Foundation
- AP
- Artesunate-pyronaridine
- ASAQ
- Artesunate-amodiaquine
- BMGF
- Bill & Melinda Gates Foundation
- CCS
- Community care sites
- CM
- Case management
- DHIS2
- District Health Information Software 2
- IPTp
- Intermittent preventive treatment in pregnancy
- IRS
- Indoor residual spraying
- ITN
- Insecticide-treated nets
- LSM
- Larval source management
- MCP
- Malaria chemoprophylaxis
- MDA
- Mass drug administration of antimalarials
- MV
- Malaria vaccination
- NMCP
- National Malaria Control Programme
- NMDR
- National Malaria Data Repository
- NSP
- National Strategic Plan
- PDMC
- Post-discharge malaria chemoprevention
- RDT
- Rapid diagnostic test
- SBCC
- Social and behaviour change communication
- SMC
- Seasonal malaria chemoprevention
- TS
- Thick blood smear
- WHO
- World Health Organization